Skip to main content

and
  1. Article

    Retraction Note: EGFR and MET receptor tyrosine kinase–altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers

    Michela Garofalo, Giulia Romano, Gianpiero Di Leva, Gerard Nuovo in Nature Medicine (2022)

  2. Article

    Open Access

    ASB2 is a direct target of FLI1 that sustains NF-κB pathway activation in germinal center-derived diffuse large B-cell lymphoma

    Diffuse large B-cell lymphoma (DLBCL) comprises at least two main biologically distinct entities: germinal center B-cell (GCB) and activated B-cell (ABC) subtype. Albeit sharing common lesions, GCB and ABC DLB...

    Giulio Sartori, Sara Napoli in Journal of Experimental & Clinical Cancer … (2021)

  3. No Access

    Protocol

    Integration of Omics Data to Identify Cancer-Related MicroRNA

    MicroRNAs regulate genes involved in various biological processes and may play oncogenic or tumor suppressive roles. Many studies have investigated the relationships between microRNAs and their target genes us...

    Luciano Cascione in MicroRNA Target Identification (2019)

  4. No Access

    Article

    Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors

    Different mutations found in endometrial and prostate tumors affecting the substrate-recognition domain of SPOP, a component of the E3 ubiquitin ligase complex, result in opposing degradation activity of BET p...

    Hana Janouskova, Geniver El Tekle, Elisa Bellini, Namrata D Udeshi in Nature Medicine (2017)

  5. Article

    Open Access

    MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinoma

    A significant proportion of patients undergoing radical nephrectomy (RN) for clear-cell renal cell carcinoma (RCC) develop chronic kidney disease (CKD) within a few years following surgery. Chronic kidney dise...

    Francesco Trevisani, Michele Ghidini, Alessandro Larcher in British Journal of Cancer (2016)

  6. Article

    Correction: Corrigendum: EGFR and MET receptor tyrosine kinase–altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers

    Nat. Med. 18, 74–82 (2012); published online 11 December 2011; corrected after print 19 November 2013 In the version of this article initially published, the actin loading control of the western blot in Figure...

    Michela Garofalo, Giulia Romano, Gianpiero Di Leva, Gerard Nuovo in Nature Medicine (2014)

  7. No Access

    Chapter

    Elucidating the Role of microRNAs in Cancer Through Data Mining Techniques

    microRNAs (miRNAs) have been shown to play a crucial role in the most important biological processes and their dysregulation has been connected to a variety of diseases, including cancer. The number of computa...

    Luciano Cascione, Alfredo Ferro, Rosalba Giugno in MicroRNA Cancer Regulation (2013)

  8. No Access

    Article

    RETRACTED ARTICLE: EGFR and MET receptor tyrosine kinase–altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers

    The authors identify a set of microRNAs regulated by EGFR and MET that are involved in the oncogenic signaling exerted by these receptors and also modulate the response of tumors to targeted EGFR inhibition. T...

    Michela Garofalo, Giulia Romano, Gianpiero Di Leva, Gerard Nuovo in Nature Medicine (2012)